Clinical Drug Development Data Analysis: Concepts

PMC 6212 4 Quarter Hours
Course Level CPS - Graduate
Description Examines the process of planning, collecting, analyzing, and reporting data from drug development studies. Focuses on the goals of each phase (1–4) of the clinical drug development process and how to achieve these objectives within the confines of the FDA regulations and ICH guidelines. Covers requirements in other countries, including the UK Data Protection Act, issues related to the differences between the development of drugs for oncologic or AIDS indications compared to traditional drugs, cultural influences, current standards of therapy, the need for validated tools, and failure analyses. Prereq. (a) PJM 6000 or (b) BTC 6210, RGA 6100, and either RGA 6201 or RGA 6202.

Prerequisites

Students should refer to the CPS Prerequisite Table for course prerequisite and corequisite information.

 

Course Sections

There are no current sections scheduled for this course. Undergraduate course numbers changed beginning with the Fall 2016 term. Please make sure you are using the current course number.
Next Term Starts
  • Spring Graduate
    Apr 10, 2017 (6- and 12-week classes)
    May 22, 2017 (6-week classes)

Academic Calendar

Talk to an Enrollment Coach

We can walk you through your program options and the application process.

 

Call Toll Free:
877.668.7727
Email:
Contact Us
©